• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自组装纳米粒子在药物传递中的最新进展。

Recent Advances in Self-Assembled Nanoparticles for Drug Delivery.

机构信息

Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER, Raebareli), Lucknow (U.P.), India.

School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, Subang Jaya, Selangor, 47500, Malaysia.

出版信息

Curr Drug Deliv. 2020;17(4):279-291. doi: 10.2174/1567201817666200210122340.

DOI:10.2174/1567201817666200210122340
PMID:32039683
Abstract

The collection of different bulk materials forms the nanoparticles, where the properties of the nanoparticle are solely different from the individual components before being ensembled. Selfassembled nanoparticles are basically a group of complex functional units that are formed by gathering the individual bulk components of the system. It includes micelles, polymeric nanoparticle, carbon nanotubes, liposomes and niosomes, . This self-assembly has progressively heightened interest to control the final complex structure of the nanoparticle and its associated properties. The main challenge of formulating self-assembled nanoparticle is to improve the delivery system, bioavailability, enhance circulation time, confer molecular targeting, controlled release, protection of the incorporated drug from external environment and also serve as nanocarriers for macromolecules. Ultimately, these self-assembled nanoparticles facilitate to overcome the physiological barriers . Self-assembly is an equilibrium process where both individual and assembled components are subsisting in equilibrium. It is a bottom up approach in which molecules are assembled spontaneously, non-covalently into a stable and welldefined structure. There are different approaches that have been adopted in fabrication of self-assembled nanoparticles by the researchers. The current review is enriched with strategies for nanoparticle selfassembly, associated properties, and its application in therapy.

摘要

不同的散装材料形成纳米颗粒,纳米颗粒的性质与组装前的单个成分完全不同。自组装纳米颗粒基本上是由系统的各个体相成分聚集而成的一组复杂的功能单元。它包括胶束、聚合物纳米颗粒、碳纳米管、脂质体和非离子型脂质体等。这种自组装引起了人们越来越大的兴趣,以控制纳米颗粒的最终复杂结构及其相关特性。自组装纳米颗粒的主要挑战是提高输送系统、生物利用度、延长循环时间、赋予分子靶向性、控制释放、保护包裹药物免受外部环境影响,同时也作为大分子的纳米载体。最终,这些自组装纳米颗粒有助于克服生理屏障。自组装是一个平衡过程,其中个体和组装的成分都处于平衡状态。这是一种自下而上的方法,其中分子自发地、非共价地组装成稳定且定义明确的结构。研究人员采用了不同的方法来制备自组装纳米颗粒。本综述丰富了纳米颗粒自组装的策略、相关性质及其在治疗中的应用。

相似文献

1
Recent Advances in Self-Assembled Nanoparticles for Drug Delivery.自组装纳米粒子在药物传递中的最新进展。
Curr Drug Deliv. 2020;17(4):279-291. doi: 10.2174/1567201817666200210122340.
2
Self-assembled polymeric nanoparticle of PEGylated chitosan-ceramide conjugate for systemic delivery of paclitaxel.用于紫杉醇全身递送的聚乙二醇化壳聚糖-神经酰胺共轭物自组装聚合物纳米颗粒。
J Drug Target. 2014 Nov;22(9):813-21. doi: 10.3109/1061186X.2014.930469. Epub 2014 Jun 25.
3
Peptide-directed self-assembly of functionalized polymeric nanoparticles. Part II: effects of nanoparticle composition on assembly behavior and multiple drug loading ability.肽导向的功能化聚合物纳米颗粒的自组装。第二部分:纳米颗粒组成对组装行为和多种药物负载能力的影响。
Macromol Biosci. 2015 Apr;15(4):568-82. doi: 10.1002/mabi.201400438. Epub 2014 Dec 4.
4
Advances in the synthesis and application of nanoparticles for drug delivery.用于药物递送的纳米颗粒的合成与应用进展。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015 Jul-Aug;7(4):494-508. doi: 10.1002/wnan.1325. Epub 2015 Jan 13.
5
Combining Nanoparticle Shape Modulation and Polymersome Technology in Drug Delivery.结合纳米颗粒形状调制和聚合物泡囊技术进行药物传递。
ACS Appl Bio Mater. 2021 Apr 19;4(4):2853-2862. doi: 10.1021/acsabm.1c00203. Epub 2021 Mar 8.
6
Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.脂质体:从临床确立的药物传递系统到治疗诊断纳米医学的纳米颗粒平台。
Acc Chem Res. 2011 Oct 18;44(10):1094-104. doi: 10.1021/ar200105p. Epub 2011 Aug 3.
7
Goblet cell targeting nanoparticle containing drug-loaded micelle cores for oral delivery of insulin.用于口服递送胰岛素的载药胶束核靶向杯状细胞的纳米颗粒。
Int J Pharm. 2015 Dec 30;496(2):993-1005. doi: 10.1016/j.ijpharm.2015.10.078. Epub 2015 Nov 2.
8
Peptide-directed self-assembly of functionalized polymeric nanoparticles part I: design and self-assembly of peptide-copolymer conjugates into nanoparticle fibers and 3D scaffolds.肽导向的功能化聚合物纳米颗粒的自组装 第一部分:肽-共聚物缀合物自组装成纳米颗粒纤维和三维支架的设计与自组装
Macromol Biosci. 2014 Jun;14(6):853-71. doi: 10.1002/mabi.201300569. Epub 2014 Mar 7.
9
Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies.纳米医学方法在西罗莫司传递中的应用:药物性质和临床前研究综述。
Artif Cells Nanomed Biotechnol. 2018;46(sup1):1-14. doi: 10.1080/21691401.2017.1408123. Epub 2017 Nov 29.
10
Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications.近年来非离子表面活性剂囊泡(niosomes)的研究进展:制备、表征、药物和化妆品应用。
Eur J Pharm Biopharm. 2019 Nov;144:18-39. doi: 10.1016/j.ejpb.2019.08.015. Epub 2019 Aug 22.

引用本文的文献

1
Surfactant-Enabled Nanocarriers in Breast Cancer Therapy: Targeted Delivery and Multidrug Resistance Reversal.用于乳腺癌治疗的表面活性剂纳米载体:靶向递送与多药耐药逆转
Pharmaceutics. 2025 Jun 13;17(6):779. doi: 10.3390/pharmaceutics17060779.
2
A Systematic Review of Nanoparticle-Mediated Ferroptosis in Glioma Therapy.纳米颗粒介导的铁死亡在胶质瘤治疗中的系统评价
Int J Nanomedicine. 2025 May 6;20:5779-5797. doi: 10.2147/IJN.S523008. eCollection 2025.
3
How Advanced are Self-Assembled Nanomaterials for Targeted Drug Delivery? A Comprehensive Review of the Literature.
用于靶向药物递送的自组装纳米材料有多先进?文献综述
Int J Nanomedicine. 2025 Feb 19;20:2133-2161. doi: 10.2147/IJN.S490444. eCollection 2025.
4
Flexible Morphological Regulation of Photothermal Nanodrugs: Understanding the Relationship between the Structure, Photothermal Effect, and Tumoral Biodistribution.光热纳米药物的灵活形态调控:理解结构、光热效应与肿瘤生物分布之间的关系
ACS Nano. 2025 Jan 21;19(2):2799-2808. doi: 10.1021/acsnano.4c15587. Epub 2025 Jan 9.
5
Biopharmaceutical and pharmacokinetic attributes to drive nanoformulations of small molecule tyrosine kinase inhibitors.推动小分子酪氨酸激酶抑制剂纳米制剂的生物制药和药代动力学特性。
Asian J Pharm Sci. 2024 Dec;19(6):100980. doi: 10.1016/j.ajps.2024.100980. Epub 2024 Oct 26.
6
Self-assembled lipid-based nanoparticles for chemotherapy against breast cancer.用于乳腺癌化疗的自组装脂质基纳米颗粒。
Front Bioeng Biotechnol. 2024 Oct 29;12:1482637. doi: 10.3389/fbioe.2024.1482637. eCollection 2024.
7
Preparation, Evaluation, and Bioinformatics Study of Hyaluronic Acid-Modified Ginsenoside Rb1 Self-Assembled Nanoparticles for Treating Cardiovascular Diseases.透明质酸修饰的人参皂苷 Rb1 自组装纳米粒的制备、评价及用于治疗心血管疾病的生物信息学研究。
Molecules. 2024 Sep 18;29(18):4425. doi: 10.3390/molecules29184425.
8
Self-Assembly of Polymers and Their Applications in the Fields of Biomedicine and Materials.聚合物的自组装及其在生物医学和材料领域的应用。
Polymers (Basel). 2024 Jul 23;16(15):2097. doi: 10.3390/polym16152097.
9
Immunocyte membrane-derived biomimetic nano-drug delivery system: a pioneering platform for tumour immunotherapy.免疫细胞膜衍生仿生纳米药物传递系统:肿瘤免疫治疗的开创性平台。
Acta Pharmacol Sin. 2024 Dec;45(12):2455-2473. doi: 10.1038/s41401-024-01355-z. Epub 2024 Jul 31.
10
Biological Activities and Solubilization Methodologies of Naringin.柚皮苷的生物活性及增溶方法
Foods. 2023 Jun 9;12(12):2327. doi: 10.3390/foods12122327.